Founded in 2007, we are a global commercial-stage biotechnology company committed to unleashing the power of innovative vaccines to save lives and improve health around the world. From GenHunter, we in-licensed the Trimer-Tag™ technology platform, a product development platform for the creation of novel vaccines. Our mission is to harness transformative science and global partnerships to bring innovative vaccines to populations worldwide.

Stock Quote

Data Provided by Refinitiv. Minimum 15 minutes delayed.

Print Page
RSS Feeds
Contact IR/Media